ProAssurance (NYSE:PRA) Releases Earnings Results, Beats Expectations By $0.19 EPS

ProAssurance (NYSE:PRA) posted its quarterly earnings results on Monday. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.19, Zacks reports. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%.

ProAssurance Stock Up 0.2 %

Shares of PRA stock traded up $0.03 during trading hours on Monday, reaching $14.02. 393,523 shares of the company’s stock were exchanged, compared to its average volume of 186,591. ProAssurance has a 1 year low of $10.76 and a 1 year high of $17.79. The stock has a market cap of $717.21 million, a PE ratio of 16.89 and a beta of 0.27. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The stock’s fifty day moving average price is $15.19 and its two-hundred day moving average price is $15.01.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on PRA shares. StockNews.com raised ProAssurance from a “hold” rating to a “buy” rating in a research report on Thursday, December 26th. Truist Financial increased their price objective on shares of ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, November 12th. Finally, Piper Sandler lowered shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 target price for the company. in a report on Monday, November 11th.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.